Ticker Details
ZOETIS INC. Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
IPO Date:	February 1, 2013
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$50.46B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.13 | 1.00%
Avg Daily Range (30 D):	$1.55 | 1.30%
Avg Daily Range (90 D):	$1.38 | 1.13%

Institutional Daily Volume
Avg Daily Volume:	2.5M
Avg Daily Volume (30 D):	2.71M
Avg Daily Volume (90 D):	3.53M

Trade Size
Avg Trade Size (Sh.):	91
Avg Trade Size (Sh.) (30 D):	53
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	27,697
Avg Institutional Trade:	$7.99M
Avg Institutional Trade (30 D):	$11.42M
Avg Institutional Trade (90 D):	$10.73M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	8

Market Closing Trades
Avg Closing Trade:	$34.96M
Avg Closing Trade (30 D):	$94.36M
Avg Closing Trade (90 D):	$93.78M
Avg Closing Volume:	302.96K

News

Mar 31, 2026 @ 4:30 AM Worried About a Stock Market Crash? History Says D... Source: Josh Kohn-Lindquist

Mar 8, 2026 @ 4:27 PM 2 No-Brainer Dividend Stocks to Buy in 2026 Source: Prosper Junior Bakiny

Feb 17, 2026 @ 11:00 AM Veterinary Reference Laboratory Market Size to Rea... Source: Sns Insider

Feb 12, 2026 @ 6:24 PM Analysts Question Zoetis' Pathway To Growth As Key... Source: Vandana Singh

Feb 9, 2026 @ 1:15 PM Should You Buy Zoetis Before Feb. 12? Source: Thomas Niel

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$6.03	$1.38	$6.03
Diluted EPS	$6.02	$1.37	$6.02
Revenue	$9.47B	$2.39B	$9.47B
Gross Profit	$6.8B	$1.68B	$6.8B
Net Income / Loss	$2.67B	$603M	$2.67B
Operating Income / Loss	$3.36B	$761M	$3.36B
Cost of Revenue	$2.67B	$712M	$2.67B
Net Cash Flow	$325M	$228M	$325M
PE Ratio	19.58